|
US2951014A
(en)
|
1957-01-03 |
1960-08-30 |
Upjohn Co |
Process for a stable oil suspension
|
|
SE9900961D0
(sv)
|
1999-03-16 |
1999-03-16 |
Astra Ab |
Novel compounds
|
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
AU2003249904A1
(en)
|
2002-07-02 |
2004-01-23 |
Laboratorios S.A.L.V.A.T., S.A. |
Stable oily suspension of microgranules
|
|
SI2656854T1
(sl)
|
2003-02-04 |
2015-09-30 |
Cornell Research Foundation, Inc. |
Uporabe aromatsko-kationskega peptida
|
|
EP3167935B1
(en)
|
2003-05-01 |
2018-07-18 |
Cornell Research Foundation, Inc. |
Method and carrier complexes for delivering molecules to cells
|
|
US20070224278A1
(en)
*
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
|
CA3024434A1
(en)
|
2004-01-23 |
2005-08-11 |
Cornell Research Foundation, Inc. |
Methods for reducing oxidative damage
|
|
US20050181050A1
(en)
|
2004-01-28 |
2005-08-18 |
Collegium Pharmaceutical, Inc. |
Dosage forms using drug-loaded ion exchange resins
|
|
US7745459B2
(en)
|
2004-09-21 |
2010-06-29 |
Japan Tobacco Inc. |
Quinolizinone compound and use thereof as HIV integrase inhibitor
|
|
EP3725324A1
(en)
|
2005-09-16 |
2020-10-21 |
Cornell Research Foundation, Inc. |
Aromatic-cationic peptide for use in a method for reducing cd36 expression
|
|
AU2012202035B2
(en)
|
2005-09-16 |
2014-03-20 |
Cornell Research Foundation, Inc. |
Methods for reducing CD36 expression
|
|
US9427423B2
(en)
|
2009-03-10 |
2016-08-30 |
Atrium Medical Corporation |
Fatty-acid based particles
|
|
WO2007122624A2
(en)
|
2006-04-24 |
2007-11-01 |
Technion Research And Development Foundation Ltd. |
Non-covalent complexes of bioactive agents with starch for oral delivery
|
|
US8802128B2
(en)
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
WO2008066899A2
(en)
*
|
2006-11-28 |
2008-06-05 |
Marinus Pharmaceuticals |
Nanoparticulate formulations and methods for the making and use thereof
|
|
EP2712620A1
(en)
|
2008-02-07 |
2014-04-02 |
Cornell University |
Methods for Preventing or Treating Insulin Resistance
|
|
CN107802821A
(zh)
|
2008-02-26 |
2018-03-16 |
康奈尔大学 |
用于防止和治疗急性肾损伤的方法
|
|
US20110105417A1
(en)
|
2008-06-26 |
2011-05-05 |
The Curators Of The University Of Missouri |
Drug Conjugates
|
|
US8323615B2
(en)
|
2008-08-20 |
2012-12-04 |
Baxter International Inc. |
Methods of processing multi-phasic dispersions
|
|
CA2770688C
(en)
|
2009-08-12 |
2018-06-05 |
Cornell University |
Methods for preventing or treating metabolic syndrome
|
|
EP3603658B1
(en)
|
2009-10-05 |
2025-01-08 |
Cornell University |
Peptide for use in the treatment of heart failure resulting from hypertrophic cardiomyopathy
|
|
CA2787331A1
(en)
|
2010-01-25 |
2011-07-28 |
Hazel H. Szeto |
Aromatic-cationic peptides and uses of same
|
|
EP3332795A1
(en)
|
2010-02-26 |
2018-06-13 |
Cornell University Cornell Center For Technology, Enterprise & Commercialization ("CCTEC") |
Mitochondrial-targeted antioxidants protect against mechanical ventilation-induced diaphragm dysfunction and skeletal muscle atrophy
|
|
CN107496899A
(zh)
|
2011-09-29 |
2017-12-22 |
梅约医学教育与研究基金会 |
芳族阳离子肽和使用它们的方法
|
|
CA2865409C
(en)
|
2012-02-23 |
2020-07-21 |
Cornell University |
Aromatic-cationic peptides and uses of same
|
|
HK1223300A1
(zh)
*
|
2013-06-03 |
2017-07-28 |
Tolmar, Inc. |
皮质类固醇组合物
|
|
CN106102760A
(zh)
|
2013-09-27 |
2016-11-09 |
康奈尔大学 |
芳香族阳离子肽用于治疗胆固醇诱发的线粒体功能障碍的用途
|
|
CA2925757A1
(en)
|
2013-09-30 |
2015-04-02 |
Cornell University |
Cardiolipin-targeted peptides inhibit beta-amyloid oligomer toxicity
|
|
WO2015089316A1
(en)
|
2013-12-12 |
2015-06-18 |
Cornell University |
Methods for preventing and treating oral cancers
|
|
EP3082838A4
(en)
|
2013-12-16 |
2017-07-26 |
Cornell University |
Methods and compositions for treating and preventing cognitive dysfunction
|
|
PL3160985T3
(pl)
|
2014-06-30 |
2021-12-27 |
Flamma S.P.A. |
Sposób wytwarzania d-arginylo-2,6-dimetylo-l-tyrozylo-l-lizylo-l-fenyloalaninoamidu
|
|
KR20170040798A
(ko)
|
2014-08-08 |
2017-04-13 |
포사이트 비젼4, 인크. |
수용체 티로신 키나제 억제제의 안정한 가용성 제제 및 그의 제조 방법
|
|
EP3203986A4
(en)
|
2014-10-10 |
2018-08-08 |
Andreas Voigt |
Mg stearate - based composite nanoparticles, methods of preparation and applications
|
|
HUP1500055A1
(hu)
|
2015-02-09 |
2016-08-29 |
Druggability Technologies Ip Holdco Ltd |
Abirateron acetát komplexei, eljárás elõállításukra, és az azokat tartalmazó gyógyászati készítmények
|
|
US20170224764A1
(en)
|
2016-02-10 |
2017-08-10 |
Cornell University |
Therapeutic targeting of mitochondria to prevent osteoarthritis
|
|
US10870678B2
(en)
|
2016-04-11 |
2020-12-22 |
Arcuate Therapeutics, Inc. |
Chiral peptides
|
|
SG11201809490YA
(en)
|
2016-04-29 |
2018-11-29 |
Enceladus Pharmaceuticals B V |
Liposomal corticosteroids for topical injection in inflamed lesions or areas
|
|
EP3257863A1
(en)
|
2016-06-16 |
2017-12-20 |
Université de Strasbourg |
Flourous metabolically stable peptide analogs
|
|
CN110087667A
(zh)
|
2016-08-16 |
2019-08-02 |
隐形生物治疗公司 |
Elamipretide的基于N-羧基酸酐的规模合成
|
|
PT3548091T
(pt)
*
|
2016-11-29 |
2022-01-21 |
Oculis SA |
Preparação de complexos sólidos de ciclodextrina para administração oftálmica de ingrediente farmacêutico ativo
|
|
US20200392497A1
(en)
|
2017-12-08 |
2020-12-17 |
University Of Washington |
Methods and compositions for detecting and promoting cardiolipin remodeling and cardiomyocyte maturation and related methods of treating mitochondrial dysfunction
|
|
US10676506B2
(en)
|
2018-01-26 |
2020-06-09 |
Stealth Biotherapeutics Corp. |
Crystalline bis- and tris-hydrochloride salt of elamipretide
|
|
ES2941266T3
(es)
|
2018-04-02 |
2023-05-19 |
Stealth Biotherapeutics Inc |
Dipéptidos cristalinos útiles en la síntesis elamipretide
|
|
AU2019290582A1
(en)
|
2018-06-19 |
2021-01-28 |
Cella Therapeutics, Llc |
Drug delivery systems comprising a neurotrophic agent, an apoptosis signaling fragment inhibitor (FAS) or FAS ligand (FASL) inhibitor, a tumor necrosis factor-alpha (TNF-alpha) or TNF receptor inhibitor, a mitochondrial peptide, an oligonucleotide, a chemokine inhibitor, or a cysteine-aspartic protease
|
|
MX2021000180A
(es)
|
2018-06-26 |
2021-06-08 |
Ribonova Inc |
Métodos para tratar la disfunción mitocondrial.
|
|
WO2020255138A1
(en)
|
2019-06-20 |
2020-12-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd |
Composites and uses thereof
|